Last reviewed · How we verify
Vulvovaginal candidiasis
Approved treatments
- Brexafemme · GSK
- Brexafemme · GSK
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vulvovaginal candidiasis patent landscape — cliff calendar, originator estates, attackable patents
- Vulvovaginal candidiasis treatment landscape brief
- Vulvovaginal candidiasis treatment updates RSS
Frequently asked questions about Vulvovaginal candidiasis
What drugs treat Vulvovaginal candidiasis?
Tracked treatments include Brexafemme.
What is the treatment for Vulvovaginal candidiasis?
Standard treatment for Vulvovaginal candidiasis includes Brexafemme. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vulvovaginal candidiasis patent cliff · Vulvovaginal candidiasis CI report
- Treatment: Brexafemme · GSK
- Treatment: Brexafemme · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing